Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Prevention of Cardiovascular Events (JUPITER)
NCT00239681Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Feb 2003
- Primary completion
- Sep 2008
- Modality
- Orthosteric Ligands
- Countries
- 27
01
Overview
A Phase 3 trial of rosuvastatin in cardiovascular disease (CVD), sponsored by AstraZeneca. Started Feb 2003; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00239681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239681.